Evidence map›Paper›PMID 26735770›Full record

ArticleAmerican journal of respiratory and critical care medicine2016

Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema.

Rosa Faner, Tamara Cruz, Teresa Casserras, Alejandra López-Giraldo, Guillaume Noell, Ignacio Coca, Ruth Tal-Singer, Bruce Miller, Roberto Rodriguez-Roisin, Avrum Spira and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 159 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Towards early detection and disease interception of COPD across the lifespan.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  15. The Mediation of Circulating Inflammatory Proteins in the Causal Pathway from Immune Cells to COPD.International journal of chronic obstructive pulmonary disease · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Lung Transcriptomics Link Emphysema to Barrier Dysfunction and Macrophage Subpopulations.American journal of respiratory and critical care medicine · 2025
    Article
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Rosa Faner1 Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.
Tamara Cruz1 Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.
Teresa Casserras3 Bioinformatics Platform Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Alejandra López-Giraldo1 Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.
Guillaume Noell2 Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain.
Ignacio Coca1 Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.
Ruth Tal-Singer4 GSK R&D, King of Prussia, Pennsylvania.
Bruce Miller4 GSK R&D, King of Prussia, Pennsylvania.
Roberto Rodriguez-Roisin1 Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.
Avrum Spira6 Boston University School of Medicine, Boston, Massachusetts.
Susana G Kalko3 Bioinformatics Platform Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Alvar Agustí1 Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESBoston University · USFundació Clínic per a la Recerca Biomèdica · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleChronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation caused by a combination of airways disease (bronchiolitis) and parenchymal destruction (emphysema), whose relative proportion varies from patient to patient.

objectivesTo explore and contrast the molecular pathogenesis of emphysema and bronchiolitis in COPD.

methodsWe used network analysis of lung transcriptomics (Affymetrix arrays) in 70 former smokers with COPD to compare differential expression and gene coexpression in bronchiolitis and emphysema. MEASUREMENTS AND MAIN

resultsWe observed that in emphysema (but not in bronchiolitis) (1) up-regulated genes were enriched in ontologies related to B-cell homing and activation; (2) the immune coexpression network had a central core of B cell-related genes; (3) B-cell recruitment and immunoglobulin transcription genes (CXCL13, CCL19, and POU2AF1) correlated with emphysema severity; (4) there were lymphoid follicles (CD20(+)IgM(+)) with active B cells (phosphorylated nuclear factor-κB p65(+)), proliferation markers (Ki-67(+)), and class-switched B cells (IgG(+)); and (5) both TNFRSF17 mRNA and B cell-activating factor protein were up-regulated. These findings were by and large reproduced in a group of patients with incipient emphysema and when patients with emphysema were matched for the severity of airflow limitation of those with bronchiolitis.

conclusionsOur study identifies enrichment in B cell-related genes in patients with COPD with emphysema that is absent in bronchiolitis. These observations contribute to a better understanding of COPD pathobiology and may open new therapeutic opportunities for patients with COPD.

Indexed as

AgedB-LymphocytesFemaleGene Expression ProfilingHumansLungMaleMiddle AgedPulmonary EmphysemaCCL19CXCL13inflammationlymphoid folliclessmoking

Identifiers

PMID26735770
OpenAlexW2224176468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.